Alexey A. Matskevich

Director Técnico/Científico/I+D en TheraMAB LLC .

Consumer Services

Health Technology

Perfil

Alexey A.
Matskevich is currently the Chief Scientific Officer at TheraMAB LLC.
Prior to this, he worked as a Senior Research Associate at the University of Zurich, the University of Lausanne, and the University of Strasbourg.
He received his graduate and doctorate degrees from Moscow State University Lomonosov.

Cargos activos de Alexey A. Matskevich

Empresas	Cargo	Inicio
TheraMAB LLC TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia.	Director Técnico/Científico/I+D	-

Todos los cargos activos de Alexey A. Matskevich

Antiguos cargos conocidos de Alexey A. Matskevich.

Empresas	Cargo	Fin
University of Lausanne	Corporate Officer/Principal	01/01/2009
University of Zurich	Corporate Officer/Principal	01/01/2008
University of Strasbourg	Corporate Officer/Principal	01/01/2005

Ver el detalle de la experiencia de Alexey A. Matskevich.

Formación de Alexey A. Matskevich.

Moscow State University Lomonosov

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Alexey A. Matskevich.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
TheraMAB LLC TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia.	Health Technology